The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19
Open accessAbstract
The ongoing global pandemic (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a huge public health issue. Hence, we devised a multiplex reverse transcription loop-mediated isothermal amplification (mRT-LAMP) coupled with a nanoparticle-based lateral flow biosensor (LFB) assay (mRT-LAMP-LFB) for diagnosing COVID-19. Using two LAMP primer sets, the ORF1ab (opening reading frame 1a/b) and N (nucleoprotein) genes of SARS-CoV-2 were simultaneously amplified in a single-tube reaction, and detected with the diagnosis results easily interpreted by LFB. In presence of FITC (fluorescein)-/digoxin- and biotin-labeled primers, mRT-LAMP produced numerous FITC-/digoxin- and biotin-attached duplex amplicons, which were determined by LFB through immunoreactions (FITC/digoxin on the duplex and anti-FITC/digoxin on the test line of LFB) and biotin/treptavidin interaction (biotin on the duplex and strptavidin on the polymerase nanoparticle). The accumulation of nanoparticles leaded a characteristic crimson band, enabling multiplex analysis of ORF1ab and N gene without instrumentation. The limit of detection (LoD) of COVID-19 mRT-LAMP-LFB was 12 copies (for each detection target) per reaction, and no cross-reactivity was generated from non-SARS-CoV-2 templates. The analytical sensitivity of SARS-CoV-2 was 100% (33/33 oropharynx swab samples collected from COVID-19 patients), and the assay's specificity was also 100% (96/96 oropharynx swab samples collected from non-COVID-19 patients). The total diagnostic test can be completed within 1 h from sample collection to result interpretation. In sum, the COVID-19 mRT-LAMP-LFB assay is a promising tool for diagnosing SARS-CoV-2 infections in frontline public health field and clinical laboratories, especially from resource-poor regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationLu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationA new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Self-citationMolecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
Chu, D. K. W., Pan, Y., Cheng, S. M. S., Hui, K. P. Y., Krishnan, P., Liu, Y., Ng, D. Y. M., Wan, C. K. C., Yang, P., Wang, Q., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa029 · Cited by 1,278
COVID-19: what is next for public health?
Heymann, D. L., & Shindo, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30374-3 · Cited by 1,138
Wong, Y.-P., Othman, S., Lau, Y.-L., Radu, S., & Chee, H.-Y. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13647 · Cited by 712
Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances
Kaneko, H., Kawana, T., Fukushima, E., & Suzutani, T. (2007) · Journal of Biochemical and Biophysical Methods · doi:10.1016/j.jbbm.2006.08.008 · Cited by 707
Nanoparticle-based lateral flow biosensors
Quesada-González, D., & Merkoçi, A. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.05.050 · Cited by 597
Yu, L., Wu, S., Hao, X., Dong, X., Mao, L., Pelechano, V., Chen, W.-H., & Yin, X. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa102 · Cited by 477
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
Suo, T., Liu, X., Feng, J., Guo, M., Hu, W., Guo, D., Ullah, H., Yang, Y., Zhang, Q., Wang, X., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1772678 · Cited by 450
Self-citationDiagnostic methods and potential portable biosensors for coronavirus disease 2019
Cui, F., & Zhou, H. S. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112349 · Cited by 373
Schoepp, N. G., Schlappi, T. S., Curtis, M. S., Butkovich, S. S., Miller, S., Humphries, R. M., & Ismagilov, R. F. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3693 · Cited by 237
National Cancer Institute (2020) · Definitions · doi:10.32388/mgxdv0 · Cited by 158
Obande, G. A., & Singh, K. K. B. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s217571 · Cited by 154
Azizi, M., Zaferani, M., Cheong, S. H., & Abbaspourrad, A. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01206 · Cited by 114
Rapid and specific detection of Asian- and African-lineage Zika viruses
Chotiwan, N., Brewster, C. D., Magalhães, T., Weger‐Lucarelli, J., Duggal, N. K., Rückert, C., Nguyen, C., Garcia-Luna, S., Fauver, J. R., Andre, B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0538 · Cited by 102
Wang, Y., Li, H., Wang, Y., Zhang, L., Xu, J., & Ye, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00192 · Cited by 90
Self-citationWang, T., Yu, Y., Liang, X., Luo, S., He, Z., Sun, Z., Jiang, Y., Omsland, A., Zhou, P., & Song, L. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00192 · Cited by 56
Mukama, O., Nie, C., Habimana, J. D. D., Meng, X., Ting, Y., Fanuel, S., AL-Farga, A. M., Mugisha, S., Rwibasira, P., Zhang, Y., et al. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113762 · Cited by 43
Cited by
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Dinnes, J., Deeks, J. J., Adriano, A., Berhane, S., Davenport, C., Dittrich, S., Emperador, D., Takwoingi, Y., Cunningham, J., Beese, S., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013705 · Cited by 1,156
Diagnostics for SARS-CoV-2 infections
Kevadiya, B. D., Machhi, J., Herskovitz, J., Oleynikov, M. D., Blomberg, W. R., Bajwa, N., Soni, D., Das, S., Hasan, M., Patel, M., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00906-z · Cited by 833
COVID-19 diagnosis —A review of current methods
Yüce, M., Filiztekin, E., & Özkaya, K. G. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112752 · Cited by 757
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Dinnes, J., Deeks, J. J., Berhane, S., Taylor, M., Adriano, A., Davenport, C., Dittrich, S., Emperador, D., Takwoingi, Y., Cunningham, J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013705.pub2 · Cited by 591
Esbin, M. N., Whitney, O. N., Chong, S., Maurer, A., Darzacq, X., & Tjian, R. (2020) · RNA · doi:10.1261/rna.076232.120 · Cited by 477
Metadata
- Authors
- Zhu, X., Wang, X., Han, L., Chen, T., Wang, L., Li, H., Li, S., He, L., Fu, X., Chen, S., Xing, M., Chen, H., & Wang, Y.
- Venue
- Biosensors and Bioelectronics
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 166
- Pages
- 112437
- ISSN
- 0956-5663 (ISSN-L)
- OpenAlex
- W3042813589
- Cited by
- 454
- References
- 23
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.